Dr. Jeffrey NeulDr Jeffrey Neul is the Annette Schaffer Eskind Chair, Director, and a professor of pediatrics for the neurology and pharmacology divisions at Vanderbilt Kenndey Center.

Dr. Neul received his M.D. and Ph.D. from the University of Chicago, Illinois, and completed his residency and fellowship programs at Baylor College of Medicine. He has board certification in Neurology, with Special Competency in Child Neurology and is a member of the Child Neurology Society, the American Academy of Neurology, and the Society for Neuroscience. He is active both in laboratory and clinical research, and these projects are funded by the National Institutes of Health (NIH) and the International Rett Syndrome Foundation.

Dr. Neul is interested in translating the knowledge acquired from basic science research into potential therapies for Rett syndrome. He is actively using mouse models of Rett syndrome to expose the pathophysiological mechanisms of disease and to conduct preclinical trials of potential therapies. Dr. Nuel is currently seeing FOXG1 patients, and is very excited to begin this new chapter of research. He will soon begin to study the genetic aspects of FOXG1 by using mouse models to further understand the various mutations, specifically what are the “downstream effects” of FOXG1. FOXG1 is believed to be one of the first genes developed in utero that governs brain development, and he will be determining what genes develop after it, and how FOXG1 may turn these genes “off” or “on.”